Bioceres Crop Solutions Corp. · NASDAQ:BIOX
Bioceres Crop Solutions — Q3 2025 Earnings Presentation
18 slides from Bioceres Crop Solutions's earnings presentation, May 21, 2025
Slide 1: Fiscal Third Quarter 2025
Fiscal Third Quarter 2025 May / 2025
Slide 2: Disclaimer
BIOCERES CROP SOLUTIONS Disclaimer Industry and Market Data Unless otherwise noted, the forecasted industry and market data contained in the assumptions for the projections are based upon the Company’s management estimates For example, other companies may calculate non-IFRS measures differently, or
Slide 3: Key Business & Financial Highlights
BIOCERES CROP SOLUTIONS Key Business & Financial Highlights ● Total revenues were $60.6 million in 3Q25, compared to $84.0 million for the same quarter last year, primarily due to an expected $15.7 year-over-year negative difference related to the accrual in 3Q24 of Syngenta’s initial downpayment. ●
Slide 4: 3Q25 Revenue by Segment
BIOCERES CROP SOLUTIONS 3Q25 Revenue by Segment 3Q25 Revenue Bridge Key Drivers ($ Million) ($ Million) -28% Expected year-over-year decline, primarily related to the accrual of Syngenta’s initial 10.9 11.8 downpayment in 3Q24. +26% -59% 84.0 (15.7) Usual seasonal slowdown limits revenue- Total Reve
Slide 5: 3Q25 Gross Profit by Segment
BIOCERES CROP SOLUTIONS 3Q25 Gross Profit by Segment ($ Million) 3Q24 3Q25 Reporting Segment Key Drivers by Segment Gross profit aligned with sales performance, Crop while gross margin improved from 38% to 42.6 23.8 - 44% YoY Protection 41% driven by prioritization of high-margin proprietary adjuvan
Slide 6: 3Q25 Adjusted EBITDA
BIOCERES CROP SOLUTIONS 3Q25 Adjusted 3Q25 EBITDA1 ($ Million) 21.1 (15.7) Decline mainly explained by the expected reduction of $15.7 million in Crop Nutrition gross profit related to the accrual of Syngenta’s initial downpayment in 3Q24. Other Income reflects beneficial exchange of non-core soybea
Slide 7: 3Q25 Cash Flow Performance
BIOCERES CROP SOLUTIONS 3Q25 Cash Flow Performance ($ Million) 3Q24 3Q25 Change $40.7 million year-over-year improvement in net cash generated by operating activities, primarily driven by working capital optimization: Net cash flows generated by operating activities (17.4) 23.3 40.7 Continued just-i
Slide 8: Balance Sheet & Cash Position
BIOCERES CROP SOLUTIONS Balance Sheet 2Q25 ($ Million) 3Q25 & Cash Position ($ Million) ($ Million) Net Debt Net Debt 3.68x 4.13x Adj. EBITDA1 Adj. EBITDA1 Positive cash flow dynamics were favorable to the sequential reduction of net financial debt. 238.3 217.4 269.5 256.8 1. Please refer to “Use of
Slide 9: HB4 / Seed Update
BIOCERES CROP SOLUTIONS HB4 / Seed Update ● Soybean harvest delayed in Argentina due to late season rains. Variety performance results expected for June/July. • GDM-Verdeca collaboration: GDM expected to launch new varieties to multipliers in the upcoming season. • Generation HB4 program to continue
Slide 10: Seed Reorganization Process
BIOCERES CROP SOLUTIONS Seed Reorganization Process ● Annual savings estimated at ~$5 million • Reduced personnel and mobility costs in alignment with the new business model, resulting in a 68% decrease in payroll expenses. • New wheat breeding arrangement between Florimond Desprez and Trigall Genet
Slide 11: Rinotec Platform
BIOCERES CROP SOLUTIONS Rinotec Platform Targeting in furrow ● Conventional acreage spans both row and specialty crops, including applications for tuber crops corn, soybean, cotton, potato, sweet potato, tree nuts, citrus, berries, fruiting vegetables, and melons, among others. ● Regulatory approval
Slide 12: Key Commercial Focus Areas FY26-28
BIOCERES CROP SOLUTIONS Key Commercial Focus Areas FY26-28 Leverage innovation from our Strengthening our platform technology platforms—UBP, Leverage our portfolio of key Continue strengthening presence in Brazil, the US, UHC, Rinotec, and Rizoderma— biological AIs to enhance the brand recognition a
Slide 13: Exhibits
Exhibit Ae S ZZ jor Sane ES - e, '
Slide 14: Unaudited Consolidated Statement of Comprehensive Income
BIOCERES CROP SOLUTIONS Three-month period ended Three-month period ended Unaudited 3/31/2025 3/31/2024 Revenues from contracts with customers 59.6 84.0 Consolidated Initial recognition and changes in the fair value of biological assets at the point of harvest Cost of sales 1.0 (36.7) (0.1) (41.3) S
Slide 15: Unaudited Consolidated Statement of Comprehensive Cash Flows
BIOCERES CROP SOLUTIONS Three-month period ended Three-month period ended Unaudited OPERATING ACTIVITIES 03/31/2025 03/31/2024 Consolidated Profit / (Loss) for the period Adjustments to reconcile profit to net cash flows (1.6) 9.8 Statement of Income tax Financial results (4.0) 6.5 (1.0) 4.4 Compreh
Slide 16: Unaudited Consolidated Statement of Comprehensive Cash Flows (cont.)
BIOCERES CROP SOLUTIONS Unaudited Three-month period ended Three-month period ended 03/31/2025 03/31/2024 Consolidated INVESTING ACTIVITIES Proceeds from sale of property, plant and equipment 0.0 0.1 Statement of Proceeds from financial assets 5.1 - Investment in financial assets (4.4) 4.5 Purchase
Slide 17: Non-IFRS Financial Measures
BIOCERES CROP SOLUTIONS Non-IFRS Financial Measures Adjusted EBITDA The company defines adjusted EBITDA as net income/(loss) exclusive of • Other companies may calculate adjusted EBITDA and similarly titled financial income/(costs), income tax benefit/(expense), depreciation, measures differently, l
Slide 18: Contact Us: Investor Relations
Contact Us: Investor Relations Investorrelations@biocerescrops.com // Investors.biocerescrops.com
Bioceres Crop Solutions — Q3 2025 Earnings Presentation on 6ix